Howard E Gendelman MD, Igor Grant MD, Ian Paul Everall MD, Howard S Fox MD, Harris A Gelbard MD, Stuart A Lipton MD, Susan Swindells Mbbs
Neurology of AIDS
Howard E Gendelman MD, Igor Grant MD, Ian Paul Everall MD, Howard S Fox MD, Harris A Gelbard MD, Stuart A Lipton MD, Susan Swindells Mbbs
Neurology of AIDS
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Fully updated and extensively illustrated this new edition covers each of neurological complications of AIDS. From basic science to clinical care and epidemiological disease patters, The Neurology of AIDS is the only complete textbook available on AIDS neurology, and the only one comprehensive enough to stand alone in each segment of study in brain disorders affected by the HIV.
Andere Kunden interessierten sich auch für
- Mary Ann CohenHandbook of AIDS Psychiatry107,99 €
- Sudhir Gupta (Hrsg.)Immunology of HIV Infection239,99 €
- Reverse Transcriptase Inhibitors in HIV/AIDS Therapy161,99 €
- Seth C. Kalichman (ed.)Positive Prevention119,99 €
- HIV and Psychiatry99,99 €
- Jean-Marie AndrieuCell Activation and Apoptosis in HIV Infection59,99 €
- Kenneth Citron / Marie Josée Brouillette / Alexandra Beckett (eds.)HIV and Psychiatry117,99 €
-
-
-
Fully updated and extensively illustrated this new edition covers each of neurological complications of AIDS. From basic science to clinical care and epidemiological disease patters, The Neurology of AIDS is the only complete textbook available on AIDS neurology, and the only one comprehensive enough to stand alone in each segment of study in brain disorders affected by the HIV.
Produktdetails
- Produktdetails
- Verlag: Oxford University Press, USA
- 3rd edition
- Seitenzahl: 1160
- Erscheinungstermin: 29. November 2011
- Englisch
- Abmessung: 286mm x 230mm x 60mm
- Gewicht: 3448g
- ISBN-13: 9780195399349
- ISBN-10: 019539934X
- Artikelnr.: 34007179
- Verlag: Oxford University Press, USA
- 3rd edition
- Seitenzahl: 1160
- Erscheinungstermin: 29. November 2011
- Englisch
- Abmessung: 286mm x 230mm x 60mm
- Gewicht: 3448g
- ISBN-13: 9780195399349
- ISBN-10: 019539934X
- Artikelnr.: 34007179
Howard E. Gendelman, MD, Professor and Chair, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center Omaha, NE. Igor Grant, MD, Distinguished Professor of Psychiatry, Director, HIV Neurobehavioral Research Program, University of California-San Diego, La Jolla, CA. Ian Paul Everall, MD, PhD, Professor of Psychiatry and Head of Department, University of Melbourne, Victoria, Australia. Howard S. Fox, MD, PhD, Professor, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE. Harris A. Gelbard, MD, PhD, Director of The Center for Neural Development and Disease, Professor of Neurology, Pediatrics, Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY. Stuart A. Lipton, MD, PhD, Professor and Scientific Director, Sanford-Burnham Medical Research Institute; Adjunct Professor of Neurosciences, University of California-San Diego; Adjunct Professor, The Salk Institute for Biological Studies and The Scripps Research Institute, La Jolla, CA. Susan Swindells, MBBS, Professor of Medicine, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE.
* Section 1. HIV-1 Biology and Immunology * 1.1. HIV-1 Biology
Michael Bukrinsky and Sergey Iordanskiy * 1.2. HIV-1 Immunology
Sabita Roy
Subhash Dhawan
Shilpa Buch
and Krishnakumar Devadas * 1.3 Chemokines
Richard J. Miller * 1.4 Viral and host genetic factors
Christopher Power
Jennifer A. McCombe
Shaona Acharjee
and M. John Gill * 1.5 Genetic Susceptibilities in neuroAIDS
Sunil K. Ahuja
Srinivas Mummidi
Jason F. Okulicz
Edwina J. Wright
and Weijing He * Section 2. Innate and Cellular Immunity and Neurogenesis * 2.1. Mononuclear phagocytes
Kenneth C. Williams
William Hickey
Tricia H. Burdo
and Caroline Soulas * 2.2. Microglia
Sunhee C. Lee * 2.3. Astrocytes
Etty N. Benveniste
Lisa N. Akhtar
and Brandi J. Baker * 2.4. Adaptive Immunity
Howard E. Gendelman
Jessica A.L. Hutter
Larisa Poluektova
and Subhash Dhawan * 2.5. Vaccines
R. Lee Mosley
Max V. Kuenstling
and Eric J. Benner * 2.6. Neurogenesis
Jialin C. Zheng
James B Reinecke
Hui Peng
Yunlong Huang
and Qiang Chen * Section 3. Blood brain barrier and HIV CNS Entry * 3.1. Blood brain barrier: Structure and function
William A. Banks * 3.2. Endothelial cell biology and HIV-1 infection
Michal Toborek
Ibolya E. András
Cetewayo S. Rashid
Yu Zhong
and Shinsuke Nakagawa * 3.3. Blood-brain barrier during neuroinflammation
Yuri Persidsky and Servio H. Ramirez * 3.4. Mechanisms of viral and cell entry into the CNS
Eliseo A. Eugenin and J.W. Berman * 3.5. Monocyte-macrophages and viral CNS entry
Georgette D. Kanmogne * Section 4. Cellular and Viral Neurotoxicity and Abused Drugs * 4.1. Mononuclear phagocyte inflammation and neurotoxicity
Howard E. Gendelman
Andrea Martinez-Skinner
Ari Nowacek
and JoEllyn McMillan * 4.2. Neurotoxicity of HIV-1 proteins
Ruth Brack-Werner
Manja Meggendorfer
Ina Rothenaigner
Bianca Tigges
and Michelle Vincendea * 4.3. HIV-1 and Tat
Avindra Nath
Wenxue Li
Guanhan Li
and Joseph Steiner * 4.4. HIV-1 gp120
Stuart A. Lipton
Shu-ichi Okamoto
Marcus Kaul
Ian Paul Everall
and Eliezer Masliah * 4.5. HIV-1 and cannabinoids
Guy A. Cabral and Erinn S. Raborn * 4.6. HIV-1 and METH
Howard S. Fox * 4.7. HIV-1 and Opioids
Toby K. Eisenstein
Jessica Breslow
Changcheng Song
Mathew J. Finley
William D. Cornwell
Sumedha Chugh
Joseph J. Meissler
and Thomas J. Rogers * 4.8. HIV-1 and Cocaine
Shilpa J. Buch
Honghong Yao
and Sabita Roy * Section 5. Animal models * 5.1. SIV
Janice E. Clements
M. Christine Zink
Joseph L. Mankowski
David R. Graham
and Lucio Gama * 5.2. FIV
Rick B. Meeker * 5.3. CAEV
Valgerdur Andrésdóttir
Sigurbjörg Torsteinsdóttir
and Gudmundur Georgsson * 5.4. Transgenics
Sulie L. Chang and Marley D. Kass * 5.5. Immunodeficient mice
Larisa Poluektova * 5.6. SIV and opiates
Shilpa J. Buch
Shannon Callen
Paul Cheney
and Anil Kumar * 5.7. SIV and FIV and peripheral neuropathy
Joseph L. Mankowski
Victoria A. Laast
Gigi Ebenezer
and Justin C. McArthur * 5.8. Animal models and bioimaging
R. Gilberto González
Eva-Maria Ratai
and Margaret R. Lentz * Section 6. Personal Perspectives in Living with HIV/AIDS * 6.1. Darren Kane * 6.2. Eric Glare * 6.3. James May * 6.4. Karen * 6.5. Susan Paxton * Section 7. Clinical and Pathologic Manifestations of Disease * 7.1. Prospective on HIV CNS Infections
Richard W. Price * 7.2. HAND
Igor Grant and Ned Sacktor * 7.3. Early Manifestations of CNS Disease
Serena S. Spudich * 7.4. HIV-1 Neuropathology
Benjamin B. Gelman and David J. Moore * 7.5. Peripheral Neuropathy
David M. Simpson
Kathryn J. Elliott
and Justin McArthur * 7.6. Spinal Cord Disease
Christina M. Marra * 7.7. Myopathy
Susan Morgello
Jessica Robinson-Papp
Kenneth A. Fox
and David M. Simpson * 7.8. Aging
Christian L. Achim and Virawudh Soontornniyomkij * 7.9. Addiction
R. Douglas Bruce * Chapter 8. Pathogenesis of Co-Morbid Conditions * 8.1. NeuroAIDS as an Inflammatory Disorder
Dennis L. Kolson
Denise R. Cooka
Stephanie A. Crossa
and Samantha S. Soldana * 8.2. Neuronal Injury
White Matter Disease
and Neurotrophic Factors
Dianne Langford
Eliezer Masliah
and Ian Paul Everall * 8.3. Pathobiology of HIV-related neuropathies
BJ Brew and NWS Davies * 8.4. CNS Co-morbidities
Georgette D. Kanmogne and David B. Clifford * 8.5. Opportunistic Infections
Joseph R. Berger and Bruce A. Cohen * 8.6. PML
Eugene O. Major and Maria Chiara G. Monaco * 8.7. Neoplasms
Alexis Demopoulos and Lauren Abrey * 8.8. Hepatitis C
Wenzhe Ho and Li Ye * 8.9. Psychiatric Co-Morbidities
Ian Paul Everall and Timothy B. Nguyen * Chapter 9. Diagnostics and Biomarkers * 9.1. Brain Imaging
Linda Chang
Ute Feger
and Thomas Ernst
Ph.D. * 9.2. MRI
Terry L. Jernigan
Sarah L. Archibald
and Christine Fennema-Notestine * 9.3. Psychological Evaluations
Steven Paul Woods
Jordan Elizabeth Cattie
and Igor Grant * 9.4. Viral and Cellular Biomarkers During Antiretroviral Therapy
Scott L. Letendre * 9.5. Viral Dynamics
Ronald J. Ellis and Davey M. Smith * 9.6. Viral Clades
Avindra Nath and Wenxue Li * 9.7. Proteomics and Biomarkers
Pawel Ciborowski
Gwenael Pottiez
and Jayme Wiederin * Chapter 10. Children and Adolescents * 10.1. Clinical and Pathological Features of HIV-1 Encephalopathy in Children and Adolescents
Mark Mintz
Leroy Sharer
and Lucy Civitello * 10.2. Infants
Children and Adolescents Nervous System Disease in the era of combination antiretroviral therapy
Annelies Van Rie and Anna Dow * 10.3. Psychosocial Aspects of Neurologic Impairment in Children with AIDS
Lori Wiener and Claude Mellins * 10.4. Growing up with HIV Disease
Lynnae Schwartz
Leslie K. Serchuck
and Shirley F. Delair * Chapter 11. Antiretroviral and Adjunctive Therapies * 11.1. Current Concepts in the Treatment of HIV Infection with Focus on Brain Disease
Susan Swindells and Uriel Sandkovsky * 11.2. Pharmacology of Antiretroviral Therapies
J. Allen McCutchan
Scott Letendre
Ronald J. Ellis
Brookie Best
and Edmund Capparelli * 11.3. Treatment of Opportunistic Infections Associated With Human Immunodeficiency Virus Infection
David B. Clifford * 11.4. Nanoformulated Medicines
Howard E. Gendelman
Upal Roy
Shantanu Balkundi
and JoEllyn McMillan * 11.5. Antiretroviral nanotherapies
Madhavan P.N. Nair and Zainulabedin M. Saiyed * 11.6. Adjunctive Medicines
Harris A. Gelbard and Stuart A. Lipton * Chapter 12. Psychiatry and Psychobiology * 12.1. Psychiatric Disorders
J. Hampton Atkinson
Nichole A. Duarte
and Glenn Treisman * 12.2. Neuropsychiatry of Substance Abuse
Eileen M. Martin-Thomas
Andy Levine
and Raul Gonzalez * 12.3. Psychobiology of Risk Behavior
David G. Ostrow * 12.4. Everyday Impact of HIV-Associated Neurocognitive Disorders
Thomas D. Marcotte
J. Cobb Scott
Charles H. Hinkin
and Robert K. Heaton * 12.5. Facing Legal and Ethical Challenges in the Treatment of AIDS
Glenn J. Treisman and Warren B. Treisman * 12.6. Neuropsychological Testing
Kevin R. Robertson
Kevin J. Liner
Michelle Ro
and Robert K. Heaton * 12.7. The impact of HIV subtype
cultural
and sociodemographic factors on HIV-1 infection and associated neuropathogenesis in Africa
Adelina Holguin
Damien C. Tully
and Charles Wood
Michael Bukrinsky and Sergey Iordanskiy * 1.2. HIV-1 Immunology
Sabita Roy
Subhash Dhawan
Shilpa Buch
and Krishnakumar Devadas * 1.3 Chemokines
Richard J. Miller * 1.4 Viral and host genetic factors
Christopher Power
Jennifer A. McCombe
Shaona Acharjee
and M. John Gill * 1.5 Genetic Susceptibilities in neuroAIDS
Sunil K. Ahuja
Srinivas Mummidi
Jason F. Okulicz
Edwina J. Wright
and Weijing He * Section 2. Innate and Cellular Immunity and Neurogenesis * 2.1. Mononuclear phagocytes
Kenneth C. Williams
William Hickey
Tricia H. Burdo
and Caroline Soulas * 2.2. Microglia
Sunhee C. Lee * 2.3. Astrocytes
Etty N. Benveniste
Lisa N. Akhtar
and Brandi J. Baker * 2.4. Adaptive Immunity
Howard E. Gendelman
Jessica A.L. Hutter
Larisa Poluektova
and Subhash Dhawan * 2.5. Vaccines
R. Lee Mosley
Max V. Kuenstling
and Eric J. Benner * 2.6. Neurogenesis
Jialin C. Zheng
James B Reinecke
Hui Peng
Yunlong Huang
and Qiang Chen * Section 3. Blood brain barrier and HIV CNS Entry * 3.1. Blood brain barrier: Structure and function
William A. Banks * 3.2. Endothelial cell biology and HIV-1 infection
Michal Toborek
Ibolya E. András
Cetewayo S. Rashid
Yu Zhong
and Shinsuke Nakagawa * 3.3. Blood-brain barrier during neuroinflammation
Yuri Persidsky and Servio H. Ramirez * 3.4. Mechanisms of viral and cell entry into the CNS
Eliseo A. Eugenin and J.W. Berman * 3.5. Monocyte-macrophages and viral CNS entry
Georgette D. Kanmogne * Section 4. Cellular and Viral Neurotoxicity and Abused Drugs * 4.1. Mononuclear phagocyte inflammation and neurotoxicity
Howard E. Gendelman
Andrea Martinez-Skinner
Ari Nowacek
and JoEllyn McMillan * 4.2. Neurotoxicity of HIV-1 proteins
Ruth Brack-Werner
Manja Meggendorfer
Ina Rothenaigner
Bianca Tigges
and Michelle Vincendea * 4.3. HIV-1 and Tat
Avindra Nath
Wenxue Li
Guanhan Li
and Joseph Steiner * 4.4. HIV-1 gp120
Stuart A. Lipton
Shu-ichi Okamoto
Marcus Kaul
Ian Paul Everall
and Eliezer Masliah * 4.5. HIV-1 and cannabinoids
Guy A. Cabral and Erinn S. Raborn * 4.6. HIV-1 and METH
Howard S. Fox * 4.7. HIV-1 and Opioids
Toby K. Eisenstein
Jessica Breslow
Changcheng Song
Mathew J. Finley
William D. Cornwell
Sumedha Chugh
Joseph J. Meissler
and Thomas J. Rogers * 4.8. HIV-1 and Cocaine
Shilpa J. Buch
Honghong Yao
and Sabita Roy * Section 5. Animal models * 5.1. SIV
Janice E. Clements
M. Christine Zink
Joseph L. Mankowski
David R. Graham
and Lucio Gama * 5.2. FIV
Rick B. Meeker * 5.3. CAEV
Valgerdur Andrésdóttir
Sigurbjörg Torsteinsdóttir
and Gudmundur Georgsson * 5.4. Transgenics
Sulie L. Chang and Marley D. Kass * 5.5. Immunodeficient mice
Larisa Poluektova * 5.6. SIV and opiates
Shilpa J. Buch
Shannon Callen
Paul Cheney
and Anil Kumar * 5.7. SIV and FIV and peripheral neuropathy
Joseph L. Mankowski
Victoria A. Laast
Gigi Ebenezer
and Justin C. McArthur * 5.8. Animal models and bioimaging
R. Gilberto González
Eva-Maria Ratai
and Margaret R. Lentz * Section 6. Personal Perspectives in Living with HIV/AIDS * 6.1. Darren Kane * 6.2. Eric Glare * 6.3. James May * 6.4. Karen * 6.5. Susan Paxton * Section 7. Clinical and Pathologic Manifestations of Disease * 7.1. Prospective on HIV CNS Infections
Richard W. Price * 7.2. HAND
Igor Grant and Ned Sacktor * 7.3. Early Manifestations of CNS Disease
Serena S. Spudich * 7.4. HIV-1 Neuropathology
Benjamin B. Gelman and David J. Moore * 7.5. Peripheral Neuropathy
David M. Simpson
Kathryn J. Elliott
and Justin McArthur * 7.6. Spinal Cord Disease
Christina M. Marra * 7.7. Myopathy
Susan Morgello
Jessica Robinson-Papp
Kenneth A. Fox
and David M. Simpson * 7.8. Aging
Christian L. Achim and Virawudh Soontornniyomkij * 7.9. Addiction
R. Douglas Bruce * Chapter 8. Pathogenesis of Co-Morbid Conditions * 8.1. NeuroAIDS as an Inflammatory Disorder
Dennis L. Kolson
Denise R. Cooka
Stephanie A. Crossa
and Samantha S. Soldana * 8.2. Neuronal Injury
White Matter Disease
and Neurotrophic Factors
Dianne Langford
Eliezer Masliah
and Ian Paul Everall * 8.3. Pathobiology of HIV-related neuropathies
BJ Brew and NWS Davies * 8.4. CNS Co-morbidities
Georgette D. Kanmogne and David B. Clifford * 8.5. Opportunistic Infections
Joseph R. Berger and Bruce A. Cohen * 8.6. PML
Eugene O. Major and Maria Chiara G. Monaco * 8.7. Neoplasms
Alexis Demopoulos and Lauren Abrey * 8.8. Hepatitis C
Wenzhe Ho and Li Ye * 8.9. Psychiatric Co-Morbidities
Ian Paul Everall and Timothy B. Nguyen * Chapter 9. Diagnostics and Biomarkers * 9.1. Brain Imaging
Linda Chang
Ute Feger
and Thomas Ernst
Ph.D. * 9.2. MRI
Terry L. Jernigan
Sarah L. Archibald
and Christine Fennema-Notestine * 9.3. Psychological Evaluations
Steven Paul Woods
Jordan Elizabeth Cattie
and Igor Grant * 9.4. Viral and Cellular Biomarkers During Antiretroviral Therapy
Scott L. Letendre * 9.5. Viral Dynamics
Ronald J. Ellis and Davey M. Smith * 9.6. Viral Clades
Avindra Nath and Wenxue Li * 9.7. Proteomics and Biomarkers
Pawel Ciborowski
Gwenael Pottiez
and Jayme Wiederin * Chapter 10. Children and Adolescents * 10.1. Clinical and Pathological Features of HIV-1 Encephalopathy in Children and Adolescents
Mark Mintz
Leroy Sharer
and Lucy Civitello * 10.2. Infants
Children and Adolescents Nervous System Disease in the era of combination antiretroviral therapy
Annelies Van Rie and Anna Dow * 10.3. Psychosocial Aspects of Neurologic Impairment in Children with AIDS
Lori Wiener and Claude Mellins * 10.4. Growing up with HIV Disease
Lynnae Schwartz
Leslie K. Serchuck
and Shirley F. Delair * Chapter 11. Antiretroviral and Adjunctive Therapies * 11.1. Current Concepts in the Treatment of HIV Infection with Focus on Brain Disease
Susan Swindells and Uriel Sandkovsky * 11.2. Pharmacology of Antiretroviral Therapies
J. Allen McCutchan
Scott Letendre
Ronald J. Ellis
Brookie Best
and Edmund Capparelli * 11.3. Treatment of Opportunistic Infections Associated With Human Immunodeficiency Virus Infection
David B. Clifford * 11.4. Nanoformulated Medicines
Howard E. Gendelman
Upal Roy
Shantanu Balkundi
and JoEllyn McMillan * 11.5. Antiretroviral nanotherapies
Madhavan P.N. Nair and Zainulabedin M. Saiyed * 11.6. Adjunctive Medicines
Harris A. Gelbard and Stuart A. Lipton * Chapter 12. Psychiatry and Psychobiology * 12.1. Psychiatric Disorders
J. Hampton Atkinson
Nichole A. Duarte
and Glenn Treisman * 12.2. Neuropsychiatry of Substance Abuse
Eileen M. Martin-Thomas
Andy Levine
and Raul Gonzalez * 12.3. Psychobiology of Risk Behavior
David G. Ostrow * 12.4. Everyday Impact of HIV-Associated Neurocognitive Disorders
Thomas D. Marcotte
J. Cobb Scott
Charles H. Hinkin
and Robert K. Heaton * 12.5. Facing Legal and Ethical Challenges in the Treatment of AIDS
Glenn J. Treisman and Warren B. Treisman * 12.6. Neuropsychological Testing
Kevin R. Robertson
Kevin J. Liner
Michelle Ro
and Robert K. Heaton * 12.7. The impact of HIV subtype
cultural
and sociodemographic factors on HIV-1 infection and associated neuropathogenesis in Africa
Adelina Holguin
Damien C. Tully
and Charles Wood
* Section 1. HIV-1 Biology and Immunology * 1.1. HIV-1 Biology
Michael Bukrinsky and Sergey Iordanskiy * 1.2. HIV-1 Immunology
Sabita Roy
Subhash Dhawan
Shilpa Buch
and Krishnakumar Devadas * 1.3 Chemokines
Richard J. Miller * 1.4 Viral and host genetic factors
Christopher Power
Jennifer A. McCombe
Shaona Acharjee
and M. John Gill * 1.5 Genetic Susceptibilities in neuroAIDS
Sunil K. Ahuja
Srinivas Mummidi
Jason F. Okulicz
Edwina J. Wright
and Weijing He * Section 2. Innate and Cellular Immunity and Neurogenesis * 2.1. Mononuclear phagocytes
Kenneth C. Williams
William Hickey
Tricia H. Burdo
and Caroline Soulas * 2.2. Microglia
Sunhee C. Lee * 2.3. Astrocytes
Etty N. Benveniste
Lisa N. Akhtar
and Brandi J. Baker * 2.4. Adaptive Immunity
Howard E. Gendelman
Jessica A.L. Hutter
Larisa Poluektova
and Subhash Dhawan * 2.5. Vaccines
R. Lee Mosley
Max V. Kuenstling
and Eric J. Benner * 2.6. Neurogenesis
Jialin C. Zheng
James B Reinecke
Hui Peng
Yunlong Huang
and Qiang Chen * Section 3. Blood brain barrier and HIV CNS Entry * 3.1. Blood brain barrier: Structure and function
William A. Banks * 3.2. Endothelial cell biology and HIV-1 infection
Michal Toborek
Ibolya E. András
Cetewayo S. Rashid
Yu Zhong
and Shinsuke Nakagawa * 3.3. Blood-brain barrier during neuroinflammation
Yuri Persidsky and Servio H. Ramirez * 3.4. Mechanisms of viral and cell entry into the CNS
Eliseo A. Eugenin and J.W. Berman * 3.5. Monocyte-macrophages and viral CNS entry
Georgette D. Kanmogne * Section 4. Cellular and Viral Neurotoxicity and Abused Drugs * 4.1. Mononuclear phagocyte inflammation and neurotoxicity
Howard E. Gendelman
Andrea Martinez-Skinner
Ari Nowacek
and JoEllyn McMillan * 4.2. Neurotoxicity of HIV-1 proteins
Ruth Brack-Werner
Manja Meggendorfer
Ina Rothenaigner
Bianca Tigges
and Michelle Vincendea * 4.3. HIV-1 and Tat
Avindra Nath
Wenxue Li
Guanhan Li
and Joseph Steiner * 4.4. HIV-1 gp120
Stuart A. Lipton
Shu-ichi Okamoto
Marcus Kaul
Ian Paul Everall
and Eliezer Masliah * 4.5. HIV-1 and cannabinoids
Guy A. Cabral and Erinn S. Raborn * 4.6. HIV-1 and METH
Howard S. Fox * 4.7. HIV-1 and Opioids
Toby K. Eisenstein
Jessica Breslow
Changcheng Song
Mathew J. Finley
William D. Cornwell
Sumedha Chugh
Joseph J. Meissler
and Thomas J. Rogers * 4.8. HIV-1 and Cocaine
Shilpa J. Buch
Honghong Yao
and Sabita Roy * Section 5. Animal models * 5.1. SIV
Janice E. Clements
M. Christine Zink
Joseph L. Mankowski
David R. Graham
and Lucio Gama * 5.2. FIV
Rick B. Meeker * 5.3. CAEV
Valgerdur Andrésdóttir
Sigurbjörg Torsteinsdóttir
and Gudmundur Georgsson * 5.4. Transgenics
Sulie L. Chang and Marley D. Kass * 5.5. Immunodeficient mice
Larisa Poluektova * 5.6. SIV and opiates
Shilpa J. Buch
Shannon Callen
Paul Cheney
and Anil Kumar * 5.7. SIV and FIV and peripheral neuropathy
Joseph L. Mankowski
Victoria A. Laast
Gigi Ebenezer
and Justin C. McArthur * 5.8. Animal models and bioimaging
R. Gilberto González
Eva-Maria Ratai
and Margaret R. Lentz * Section 6. Personal Perspectives in Living with HIV/AIDS * 6.1. Darren Kane * 6.2. Eric Glare * 6.3. James May * 6.4. Karen * 6.5. Susan Paxton * Section 7. Clinical and Pathologic Manifestations of Disease * 7.1. Prospective on HIV CNS Infections
Richard W. Price * 7.2. HAND
Igor Grant and Ned Sacktor * 7.3. Early Manifestations of CNS Disease
Serena S. Spudich * 7.4. HIV-1 Neuropathology
Benjamin B. Gelman and David J. Moore * 7.5. Peripheral Neuropathy
David M. Simpson
Kathryn J. Elliott
and Justin McArthur * 7.6. Spinal Cord Disease
Christina M. Marra * 7.7. Myopathy
Susan Morgello
Jessica Robinson-Papp
Kenneth A. Fox
and David M. Simpson * 7.8. Aging
Christian L. Achim and Virawudh Soontornniyomkij * 7.9. Addiction
R. Douglas Bruce * Chapter 8. Pathogenesis of Co-Morbid Conditions * 8.1. NeuroAIDS as an Inflammatory Disorder
Dennis L. Kolson
Denise R. Cooka
Stephanie A. Crossa
and Samantha S. Soldana * 8.2. Neuronal Injury
White Matter Disease
and Neurotrophic Factors
Dianne Langford
Eliezer Masliah
and Ian Paul Everall * 8.3. Pathobiology of HIV-related neuropathies
BJ Brew and NWS Davies * 8.4. CNS Co-morbidities
Georgette D. Kanmogne and David B. Clifford * 8.5. Opportunistic Infections
Joseph R. Berger and Bruce A. Cohen * 8.6. PML
Eugene O. Major and Maria Chiara G. Monaco * 8.7. Neoplasms
Alexis Demopoulos and Lauren Abrey * 8.8. Hepatitis C
Wenzhe Ho and Li Ye * 8.9. Psychiatric Co-Morbidities
Ian Paul Everall and Timothy B. Nguyen * Chapter 9. Diagnostics and Biomarkers * 9.1. Brain Imaging
Linda Chang
Ute Feger
and Thomas Ernst
Ph.D. * 9.2. MRI
Terry L. Jernigan
Sarah L. Archibald
and Christine Fennema-Notestine * 9.3. Psychological Evaluations
Steven Paul Woods
Jordan Elizabeth Cattie
and Igor Grant * 9.4. Viral and Cellular Biomarkers During Antiretroviral Therapy
Scott L. Letendre * 9.5. Viral Dynamics
Ronald J. Ellis and Davey M. Smith * 9.6. Viral Clades
Avindra Nath and Wenxue Li * 9.7. Proteomics and Biomarkers
Pawel Ciborowski
Gwenael Pottiez
and Jayme Wiederin * Chapter 10. Children and Adolescents * 10.1. Clinical and Pathological Features of HIV-1 Encephalopathy in Children and Adolescents
Mark Mintz
Leroy Sharer
and Lucy Civitello * 10.2. Infants
Children and Adolescents Nervous System Disease in the era of combination antiretroviral therapy
Annelies Van Rie and Anna Dow * 10.3. Psychosocial Aspects of Neurologic Impairment in Children with AIDS
Lori Wiener and Claude Mellins * 10.4. Growing up with HIV Disease
Lynnae Schwartz
Leslie K. Serchuck
and Shirley F. Delair * Chapter 11. Antiretroviral and Adjunctive Therapies * 11.1. Current Concepts in the Treatment of HIV Infection with Focus on Brain Disease
Susan Swindells and Uriel Sandkovsky * 11.2. Pharmacology of Antiretroviral Therapies
J. Allen McCutchan
Scott Letendre
Ronald J. Ellis
Brookie Best
and Edmund Capparelli * 11.3. Treatment of Opportunistic Infections Associated With Human Immunodeficiency Virus Infection
David B. Clifford * 11.4. Nanoformulated Medicines
Howard E. Gendelman
Upal Roy
Shantanu Balkundi
and JoEllyn McMillan * 11.5. Antiretroviral nanotherapies
Madhavan P.N. Nair and Zainulabedin M. Saiyed * 11.6. Adjunctive Medicines
Harris A. Gelbard and Stuart A. Lipton * Chapter 12. Psychiatry and Psychobiology * 12.1. Psychiatric Disorders
J. Hampton Atkinson
Nichole A. Duarte
and Glenn Treisman * 12.2. Neuropsychiatry of Substance Abuse
Eileen M. Martin-Thomas
Andy Levine
and Raul Gonzalez * 12.3. Psychobiology of Risk Behavior
David G. Ostrow * 12.4. Everyday Impact of HIV-Associated Neurocognitive Disorders
Thomas D. Marcotte
J. Cobb Scott
Charles H. Hinkin
and Robert K. Heaton * 12.5. Facing Legal and Ethical Challenges in the Treatment of AIDS
Glenn J. Treisman and Warren B. Treisman * 12.6. Neuropsychological Testing
Kevin R. Robertson
Kevin J. Liner
Michelle Ro
and Robert K. Heaton * 12.7. The impact of HIV subtype
cultural
and sociodemographic factors on HIV-1 infection and associated neuropathogenesis in Africa
Adelina Holguin
Damien C. Tully
and Charles Wood
Michael Bukrinsky and Sergey Iordanskiy * 1.2. HIV-1 Immunology
Sabita Roy
Subhash Dhawan
Shilpa Buch
and Krishnakumar Devadas * 1.3 Chemokines
Richard J. Miller * 1.4 Viral and host genetic factors
Christopher Power
Jennifer A. McCombe
Shaona Acharjee
and M. John Gill * 1.5 Genetic Susceptibilities in neuroAIDS
Sunil K. Ahuja
Srinivas Mummidi
Jason F. Okulicz
Edwina J. Wright
and Weijing He * Section 2. Innate and Cellular Immunity and Neurogenesis * 2.1. Mononuclear phagocytes
Kenneth C. Williams
William Hickey
Tricia H. Burdo
and Caroline Soulas * 2.2. Microglia
Sunhee C. Lee * 2.3. Astrocytes
Etty N. Benveniste
Lisa N. Akhtar
and Brandi J. Baker * 2.4. Adaptive Immunity
Howard E. Gendelman
Jessica A.L. Hutter
Larisa Poluektova
and Subhash Dhawan * 2.5. Vaccines
R. Lee Mosley
Max V. Kuenstling
and Eric J. Benner * 2.6. Neurogenesis
Jialin C. Zheng
James B Reinecke
Hui Peng
Yunlong Huang
and Qiang Chen * Section 3. Blood brain barrier and HIV CNS Entry * 3.1. Blood brain barrier: Structure and function
William A. Banks * 3.2. Endothelial cell biology and HIV-1 infection
Michal Toborek
Ibolya E. András
Cetewayo S. Rashid
Yu Zhong
and Shinsuke Nakagawa * 3.3. Blood-brain barrier during neuroinflammation
Yuri Persidsky and Servio H. Ramirez * 3.4. Mechanisms of viral and cell entry into the CNS
Eliseo A. Eugenin and J.W. Berman * 3.5. Monocyte-macrophages and viral CNS entry
Georgette D. Kanmogne * Section 4. Cellular and Viral Neurotoxicity and Abused Drugs * 4.1. Mononuclear phagocyte inflammation and neurotoxicity
Howard E. Gendelman
Andrea Martinez-Skinner
Ari Nowacek
and JoEllyn McMillan * 4.2. Neurotoxicity of HIV-1 proteins
Ruth Brack-Werner
Manja Meggendorfer
Ina Rothenaigner
Bianca Tigges
and Michelle Vincendea * 4.3. HIV-1 and Tat
Avindra Nath
Wenxue Li
Guanhan Li
and Joseph Steiner * 4.4. HIV-1 gp120
Stuart A. Lipton
Shu-ichi Okamoto
Marcus Kaul
Ian Paul Everall
and Eliezer Masliah * 4.5. HIV-1 and cannabinoids
Guy A. Cabral and Erinn S. Raborn * 4.6. HIV-1 and METH
Howard S. Fox * 4.7. HIV-1 and Opioids
Toby K. Eisenstein
Jessica Breslow
Changcheng Song
Mathew J. Finley
William D. Cornwell
Sumedha Chugh
Joseph J. Meissler
and Thomas J. Rogers * 4.8. HIV-1 and Cocaine
Shilpa J. Buch
Honghong Yao
and Sabita Roy * Section 5. Animal models * 5.1. SIV
Janice E. Clements
M. Christine Zink
Joseph L. Mankowski
David R. Graham
and Lucio Gama * 5.2. FIV
Rick B. Meeker * 5.3. CAEV
Valgerdur Andrésdóttir
Sigurbjörg Torsteinsdóttir
and Gudmundur Georgsson * 5.4. Transgenics
Sulie L. Chang and Marley D. Kass * 5.5. Immunodeficient mice
Larisa Poluektova * 5.6. SIV and opiates
Shilpa J. Buch
Shannon Callen
Paul Cheney
and Anil Kumar * 5.7. SIV and FIV and peripheral neuropathy
Joseph L. Mankowski
Victoria A. Laast
Gigi Ebenezer
and Justin C. McArthur * 5.8. Animal models and bioimaging
R. Gilberto González
Eva-Maria Ratai
and Margaret R. Lentz * Section 6. Personal Perspectives in Living with HIV/AIDS * 6.1. Darren Kane * 6.2. Eric Glare * 6.3. James May * 6.4. Karen * 6.5. Susan Paxton * Section 7. Clinical and Pathologic Manifestations of Disease * 7.1. Prospective on HIV CNS Infections
Richard W. Price * 7.2. HAND
Igor Grant and Ned Sacktor * 7.3. Early Manifestations of CNS Disease
Serena S. Spudich * 7.4. HIV-1 Neuropathology
Benjamin B. Gelman and David J. Moore * 7.5. Peripheral Neuropathy
David M. Simpson
Kathryn J. Elliott
and Justin McArthur * 7.6. Spinal Cord Disease
Christina M. Marra * 7.7. Myopathy
Susan Morgello
Jessica Robinson-Papp
Kenneth A. Fox
and David M. Simpson * 7.8. Aging
Christian L. Achim and Virawudh Soontornniyomkij * 7.9. Addiction
R. Douglas Bruce * Chapter 8. Pathogenesis of Co-Morbid Conditions * 8.1. NeuroAIDS as an Inflammatory Disorder
Dennis L. Kolson
Denise R. Cooka
Stephanie A. Crossa
and Samantha S. Soldana * 8.2. Neuronal Injury
White Matter Disease
and Neurotrophic Factors
Dianne Langford
Eliezer Masliah
and Ian Paul Everall * 8.3. Pathobiology of HIV-related neuropathies
BJ Brew and NWS Davies * 8.4. CNS Co-morbidities
Georgette D. Kanmogne and David B. Clifford * 8.5. Opportunistic Infections
Joseph R. Berger and Bruce A. Cohen * 8.6. PML
Eugene O. Major and Maria Chiara G. Monaco * 8.7. Neoplasms
Alexis Demopoulos and Lauren Abrey * 8.8. Hepatitis C
Wenzhe Ho and Li Ye * 8.9. Psychiatric Co-Morbidities
Ian Paul Everall and Timothy B. Nguyen * Chapter 9. Diagnostics and Biomarkers * 9.1. Brain Imaging
Linda Chang
Ute Feger
and Thomas Ernst
Ph.D. * 9.2. MRI
Terry L. Jernigan
Sarah L. Archibald
and Christine Fennema-Notestine * 9.3. Psychological Evaluations
Steven Paul Woods
Jordan Elizabeth Cattie
and Igor Grant * 9.4. Viral and Cellular Biomarkers During Antiretroviral Therapy
Scott L. Letendre * 9.5. Viral Dynamics
Ronald J. Ellis and Davey M. Smith * 9.6. Viral Clades
Avindra Nath and Wenxue Li * 9.7. Proteomics and Biomarkers
Pawel Ciborowski
Gwenael Pottiez
and Jayme Wiederin * Chapter 10. Children and Adolescents * 10.1. Clinical and Pathological Features of HIV-1 Encephalopathy in Children and Adolescents
Mark Mintz
Leroy Sharer
and Lucy Civitello * 10.2. Infants
Children and Adolescents Nervous System Disease in the era of combination antiretroviral therapy
Annelies Van Rie and Anna Dow * 10.3. Psychosocial Aspects of Neurologic Impairment in Children with AIDS
Lori Wiener and Claude Mellins * 10.4. Growing up with HIV Disease
Lynnae Schwartz
Leslie K. Serchuck
and Shirley F. Delair * Chapter 11. Antiretroviral and Adjunctive Therapies * 11.1. Current Concepts in the Treatment of HIV Infection with Focus on Brain Disease
Susan Swindells and Uriel Sandkovsky * 11.2. Pharmacology of Antiretroviral Therapies
J. Allen McCutchan
Scott Letendre
Ronald J. Ellis
Brookie Best
and Edmund Capparelli * 11.3. Treatment of Opportunistic Infections Associated With Human Immunodeficiency Virus Infection
David B. Clifford * 11.4. Nanoformulated Medicines
Howard E. Gendelman
Upal Roy
Shantanu Balkundi
and JoEllyn McMillan * 11.5. Antiretroviral nanotherapies
Madhavan P.N. Nair and Zainulabedin M. Saiyed * 11.6. Adjunctive Medicines
Harris A. Gelbard and Stuart A. Lipton * Chapter 12. Psychiatry and Psychobiology * 12.1. Psychiatric Disorders
J. Hampton Atkinson
Nichole A. Duarte
and Glenn Treisman * 12.2. Neuropsychiatry of Substance Abuse
Eileen M. Martin-Thomas
Andy Levine
and Raul Gonzalez * 12.3. Psychobiology of Risk Behavior
David G. Ostrow * 12.4. Everyday Impact of HIV-Associated Neurocognitive Disorders
Thomas D. Marcotte
J. Cobb Scott
Charles H. Hinkin
and Robert K. Heaton * 12.5. Facing Legal and Ethical Challenges in the Treatment of AIDS
Glenn J. Treisman and Warren B. Treisman * 12.6. Neuropsychological Testing
Kevin R. Robertson
Kevin J. Liner
Michelle Ro
and Robert K. Heaton * 12.7. The impact of HIV subtype
cultural
and sociodemographic factors on HIV-1 infection and associated neuropathogenesis in Africa
Adelina Holguin
Damien C. Tully
and Charles Wood